BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Callisto Pharmaceuticals Redirects Atiprimod Clinical Development to Treat Rheumatoid Arthritis

  January 27, 2009

   · 

  1 min read
• Biotech Bay

  IMPAX Laboratories, Inc. Resolves Remaining SEC Comments on Form 10 Registration Statement

  January 27, 2009

   · 

  1 min read
• Drug Development

  Inspire Pharmaceuticals, Inc. Initiates Phase 3 Prolacria(TM) Dry Eye Trial under Special Protocol Assessment Agreement

  January 27, 2009

   · 

  1 min read
• Business

  QIAGEN Announces New President for QIAGEN Japan

  January 27, 2009

   · 

  1 min read
• FDA

  RaySearch Laboratories: First Product from Collaboration Between RaySearch and TomoTherapy Receives FDA Clearance

  January 27, 2009

   · 

  1 min read
• Lone Star Bio

  Repros Therapeutics Inc. Announces Information In Compliance With NASDAQ Marketplace Rule 4350

  January 27, 2009

   · 

  1 min read
• Genetown

  Interleukin Genetics Inc.'s Submits Plan to Regain Compliance with Continued Listing Standards

  January 27, 2009

   · 

  3 min read
• Bio NC

  ZenBio, Inc. Awarded $1.88 Million Phase II SBIR Grant for Mesothelial Cell Program

  January 27, 2009

   · 

  1 min read
• Business

  DOR BioPharma, Inc. Announces Appointment of Christopher J. Schaber, PhD, to BioNJ Board of Directors

  January 27, 2009

   · 

  6 min read
• Deals

  SYGNIS Pharma AG Release: Mandatory Offer of dievini Hopp BioTech holding GmbH & Co. KG Completed

  January 27, 2009

   · 

  2 min read